Interactions between an M. tuberculosis strain overexpressing mtrA and mononuclear phagocytes. 2013

M Fol, and L Iwan-Barańska, and P Stączek, and M Krupiński, and S Różalska, and M Kowalewicz-Kulbat, and M Druszczyńska, and M V V S Madiraju, and D Kaczmarczyk, and W Rudnicka
Department of Immunology and Infectious Biology, University of Lodz, Lodz, Poland. marekfol@poczta.onet.pl

OBJECTIVE It was previously shown that the bacterial two-component regulatory signal transduction (2CR) system MtrAB may be associated with the ability of M. tuberculosis (Mtb) to survive in macrophages. In the present work Mtb mutants: Rv-78 with overexpression of mtrA and Rv-129 with elevated level of phosphorylation-defective MtrA were used for further investigation of the potential influence of the MtrAB system on Mtb interaction with human monocytes. METHODS Flow cytometry was used to determine the expression of MHC class II molecules. The expression of genes for inducible nitric oxide synthase (iNOS) and cathepsin G was quantified by RT-PCR. The association of Mtb strains with Rab5 and Rab7 positive vacuoles was investigated applying confocal microscopy. IL-10 and IL-12 secretion by monocytes as well as the Mtb susceptibility to cathepsin G were investigated. RESULTS Mutation-carried and wild type Mtb strains inhibited MHC class II expression on monocytes to a similar extent. Monocyte stimulation with mycobacteria led to the increased production of IL-10 but no detectable amounts of IL-12 or NO were observed. Expression of the gene for iNOS was not detected while that for cathepsin G was shown, however its intensity was not associated with MtrA mutation. Mtb mutant strains were more effectively enclosed in phagosomes containing the late endosome marker Rab7 as compared to the control. CONCLUSIONS The results may confirm the importance of the MtrAB system in mycobacterial capacity for successful survival in phagocytes, especially in the context of high degree of colocalization of Mtb Rv-78 to mature phagosomes.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial

Related Publications

M Fol, and L Iwan-Barańska, and P Stączek, and M Krupiński, and S Różalska, and M Kowalewicz-Kulbat, and M Druszczyńska, and M V V S Madiraju, and D Kaczmarczyk, and W Rudnicka
August 1996, Journal of investigative medicine : the official publication of the American Federation for Clinical Research,
M Fol, and L Iwan-Barańska, and P Stączek, and M Krupiński, and S Różalska, and M Kowalewicz-Kulbat, and M Druszczyńska, and M V V S Madiraju, and D Kaczmarczyk, and W Rudnicka
February 1958, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
M Fol, and L Iwan-Barańska, and P Stączek, and M Krupiński, and S Różalska, and M Kowalewicz-Kulbat, and M Druszczyńska, and M V V S Madiraju, and D Kaczmarczyk, and W Rudnicka
June 2013, Acta microbiologica et immunologica Hungarica,
M Fol, and L Iwan-Barańska, and P Stączek, and M Krupiński, and S Różalska, and M Kowalewicz-Kulbat, and M Druszczyńska, and M V V S Madiraju, and D Kaczmarczyk, and W Rudnicka
January 1994, Voprosy virusologii,
M Fol, and L Iwan-Barańska, and P Stączek, and M Krupiński, and S Różalska, and M Kowalewicz-Kulbat, and M Druszczyńska, and M V V S Madiraju, and D Kaczmarczyk, and W Rudnicka
May 1993, Journal of medical microbiology,
M Fol, and L Iwan-Barańska, and P Stączek, and M Krupiński, and S Różalska, and M Kowalewicz-Kulbat, and M Druszczyńska, and M V V S Madiraju, and D Kaczmarczyk, and W Rudnicka
January 1996, Current topics in microbiology and immunology,
M Fol, and L Iwan-Barańska, and P Stączek, and M Krupiński, and S Różalska, and M Kowalewicz-Kulbat, and M Druszczyńska, and M V V S Madiraju, and D Kaczmarczyk, and W Rudnicka
April 1983, The Journal of clinical investigation,
M Fol, and L Iwan-Barańska, and P Stączek, and M Krupiński, and S Różalska, and M Kowalewicz-Kulbat, and M Druszczyńska, and M V V S Madiraju, and D Kaczmarczyk, and W Rudnicka
January 1993, International journal of antimicrobial agents,
M Fol, and L Iwan-Barańska, and P Stączek, and M Krupiński, and S Różalska, and M Kowalewicz-Kulbat, and M Druszczyńska, and M V V S Madiraju, and D Kaczmarczyk, and W Rudnicka
January 1952, Archiv fur Hygiene und Bakteriologie,
M Fol, and L Iwan-Barańska, and P Stączek, and M Krupiński, and S Różalska, and M Kowalewicz-Kulbat, and M Druszczyńska, and M V V S Madiraju, and D Kaczmarczyk, and W Rudnicka
March 1989, BMJ (Clinical research ed.),
Copied contents to your clipboard!